SMLR — Semler Scientific, Inc.

Summary of Semler Scientific (SMLR) Q2 2025 Earnings Call

1. Key Financial Results and Metrics

• Net Income: $66.9 million, or $5.04 per fully diluted share.
• Total Revenues: $8.2 million, a decline compared to Q2 2024.
• Operating Expenses: $10.3 million, including $1.9 million in noncash stock-based compensation and $0.5 million in legal expenses related to a DOJ settlement.
• Bitcoin Holdings: Acquired 1,444 Bitcoin in Q2 at a cost of $149.6 million, totaling 5,021 Bitcoin valued at approximately $586 million as of July 31, 2025.
• Bitcoin Yield: Year-to-date yield of 31.3%, translating to a dollar gain of $84 million.

2. Strategic Updates and Business Highlights

• Bitcoin Strategy: Semler has adopted a dual-engine strategy, leveraging its healthcare business to fund Bitcoin acquisitions. The company aims to reach 10,000 Bitcoin by the end of 2025, 42,000 by 2026, and 105,000 by 2027.
• New Subsidiary: CardioVanta was established to focus on early detection of heart failure and cardiac arrhythmia, projected to operate as a high-margin SaaS business.
• Team Expansion: Notable hires include Natalie Brunell to the Board and Joe Burnett as Director of Bitcoin Strategy, enhancing the company's Bitcoin operations.

3. Forward Guidance and Outlook

• Semler is optimistic about its healthcare business generating meaningful cash flow in the coming years, which will support further Bitcoin acquisitions.
• The company is exploring various financing options to enhance its Bitcoin treasury strategy and aims to unlock shareholder value.
• Management expressed confidence in the potential for substantial growth in both Bitcoin holdings and healthcare operations.

4. Bad News, Challenges, or Points of Concern

• Revenue Decline: The decrease in revenues is attributed to the phase-in of the 2024 CMS rate announcement affecting reimbursement for positive PAD patients, leading to reduced device usage.
• Operating Loss: The company reported a loss from operations of $1.2 million, indicating potential challenges in managing costs amidst declining revenues.
• Legal Risks: Ongoing legal expenses related to the DOJ settlement could pose financial and operational risks.

5. Notable Q&A Insights

• Competition Concerns: Management does not view the increasing number of companies adopting Bitcoin treasury strategies as a threat but rather as a means to accelerate Bitcoin adoption.
• Acquisition Announcements: While the company does not plan to make frequent acquisition announcements, it anticipates increasing the size and regularity of these announcements in the future.
• Market Positioning: Discussion on the company’s mNAV multiple highlighted the distinction between fast money and slow money strategies in the Bitcoin treasury space, emphasizing the potential for leveraging the balance sheet to enhance returns.

Overall, Semler Scientific is navigating a complex landscape with a focus on expanding its Bitcoin treasury while addressing challenges in its healthcare segment. The company remains committed to its strategic goals and is optimistic about future growth.